Search

Author/Creator Nii, Masahiro

11. Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer. (24th May 2022)

Authors:
Doki, Yuichiro; Ueno, Makoto; Hsu, Chih‐Hung; Oh, Do‐Youn; Park, Keunchil; Yamamoto, Noboru; Ioka, Tatsuya; Hara, Hiroki; Hayama, Manabu; Nii, Masahiro; Komuro, Keiko; Sugimoto, Mariko; Tahara, Makoto
Journal:
Cancer medicine
Issue:
Volume 11:Number 13(2022)
Page Start:
2550
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗